| | Intensive Performance Protocol | 10mg subcutaneous, 5x/week (weekdays) | 150mg oral, daily | Both compounds AM, pre-training | 6 weeks on, 4 weeks off | Athletic performance research, substrate utilization studies, endurance capacity trials | Higher dosing frequency and dose intensity produce more pronounced short-term shifts in RER and VO2 max, but require stricter adherence and increase washout sensitivity
Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells
Evidence comes from small clinical trials, animal studies, and mechanistic work
10.3742/OPEM.2007.7.3.261 569
Untreated heavy metal exposure can increase the risk of cardiovascular issues, such as hypertension and heart disease, as well as respiratory problems if metals are inhaled